How to Keep MS Patients Out of the Hospital

Credibility

Interest

Key Takeaway

Focusing on bladder health can help reduce hospital visits for MS patients.

What They Found

The study looked at why people with multiple sclerosis (MS) were admitted to the hospital. They found that urinary tract infections (UTIs) were the most common reason for these hospital stays, affecting about 10 out of every 100 patients. On average, MS patients stayed in the hospital for about 6 days, which is a bit longer compared to the general population. Many patients admitted to the hospital were not using any disease-modifying therapy (DMT), which are medicines that help manage MS. The researchers believe that better management of bladder health could help prevent these hospitalizations.

Who Should Care and Why

MS patients should pay attention to their bladder health because it can lead to serious issues like UTIs, which cause unnecessary hospital visits. Caregivers can help by encouraging good hydration and regular bathroom habits, which may prevent these infections. Healthcare providers might consider more education on bladder management for their MS patients to help keep them healthy at home. Reducing hospital admissions means more time spent in comfort and less disruption in daily life for both patients and caregivers. Overall, improving bladder care can lead to a better quality of life for those living with MS.

Important Considerations

The study had some limitations, including that it only looked at patients from one hospital, which may not represent all MS patients. It also didn't explore why some patients were not using DMTs, which could affect their health. These factors are important because they remind us that more research is needed to fully understand how to prevent hospitalizations in people with MS.

Categories:

MS Progression Living with MS Specific Symptoms

Article Topics:

DMTshospital admissioninpatient servicesreadmission rates

Whether you’ve recently been diagnosed with Multiple Sclerosis (MS) or are seeking to broaden your understanding of this complex, neurodegenerative disease, navigating the latest research can feel overwhelming. Studies published in respected medical journals like International journal of MS care often range from early-stage, exploratory work to advanced clinical trials. These evidence-based findings help shape new disease-modifying therapies, guide symptom management techniques, and deepen our knowledge of MS progression.

However, not all research is created equal. Some clinical research studies may have smaller sample sizes, evolving methodologies, or limitations that warrant careful interpretation. For a more comprehensive, accurate understanding, we recommend reviewing the original source material—accessible via the More Details section above—and consulting with healthcare professionals who specialize in MS care.

By presenting a wide range of MS-focused studies—spanning cutting-edge treatments, emerging therapies, and established best practices—we aim to empower patients, caregivers, and clinicians to stay informed and make well-informed decisions when managing Multiple Sclerosis.

Back to News